LDC was founded in 2008 and is a professional drug discovery company with all required infrastructure, core competencies and disciplines operating in a fully integrated way at highest industrial standards. The LDC is working closely together with an academic and industrial scientific network, e.g. the Max-Planck-Society, universities and pharmaceutical companies.
LDC functions as a facilitator to translate academic basic research results into professional drug discovery projects and high quality products – lead structures with proven efficacy in a therapeutic animal model. LDC is working on a broad portfolio of early stage drug discovery projects. The indications include cancer and metabolic syndromes, neurodegenerative diseases, inflammatory disorders and infections, as well as other conditions with high, unmet clinical needs.
LDC offers the full workflow in early pharmaceutical drug discovery in its five scientific departments: Therapeutic Antibodies, Assay development & Screening, Biology, Pharmacology, and Medicinal Chemistry (www.lead-discovery.de).